UAE MOHAP Medical Device Registration

Regulatory Oversight of MOHAP

The commercial distribution of medical devices in the United Arab Emirates is supervised by the Ministry of Health and Prevention which is commonly referred to as MOHAP. This agency ensures that all medical equipment and therapeutic products meet safety and quality standards before they can be marketed locally. While MOHAP serves as the primary federal regulator, regional entities like the Dubai Health Authority (DHA) and the Health Authority of Abu Dhabi (HAAD) play supporting roles in coordinating local health regulations.

Risk Classification for Medical Devices and IVD

In alignment with the Medical Device Regulation (MDR) frameworks, the UAE categorizes medical products based on their potential risk to patients. This classification system determines the level of technical scrutiny required for registration.

• Class IV includes high-risk, life-sustaining equipment such as cardiac pacemakers and heart valves.
• Class III covers moderate-to-high risk items that may be implanted, such as orthopedic implants and lung ventilators.
• Class II represents moderate-risk technologies that may interact with body tissues, such as surgical tools and infusion pumps.
• Class I consists of low-risk devices such as wheelchairs and stethoscopes.

For In Vitro Diagnostics (IVD), the UAE applies a separate risk-based scale labeled as Class A, B, C, and D.

Core Prerequisites for Market Access

To successfully introduce a medical product to the UAE healthcare sector, manufacturers must satisfy extensive technical and quality criteria. These mandatory requirements include providing an evaluation report from the country of origin and a valid Free Sale Certificate (FSC). Manufacturers must also submit a factory questionnaire and a letter of authorization for the local agent as well as a CE Declaration of Conformity to show alignment with safety standards. Other essential documents involve product catalogs and stability studies along with risk assessment reports and evidence of clinical evaluation to ensure safety performance.

Registration Pathway and Representative Duties

The administrative process for market entry relies on a structured sequence of evaluations involving a local presence within the UAE.

Appointment of a Local Representative

Foreign manufacturers are required to designate a local representative or licensed distributor within the UAE. This entity is tasked with managing the application process through the MOHAP electronic system and serves as the primary legal liaison for regulatory affairs.

Assessment and Final Authorization

To successfully introduce a medical product to the UAE healthcare sector, manufacturers must satisfy extensive technical and quality criteria. Mandatory requirements include providing an evaluation report from the country of origin and a valid Free Sale Certificate. Manufacturers must also submit a factory questionnaire and a letter of authorization for the local agent as well as a CE Declaration of Conformity to show alignment with safety standards. Other essential documents involve product catalogs, stability studies, and risk assessment reports alongside evidence of clinical evaluation. It is a formal regulatory requirement that all registration materials and documentation be submitted in Arabic.

Administrative Timelines and Market Maintenance

The UAE system provides specific pathways for regulatory notification and technical assessment with established timeframes.

• The official confirmation of product classification is generally finalized within 30 working days.
• The full technical registration process for the medical device typically requires approximately 3 to 6 months.
• Any major changes to the manufacturing process or device specifications must be officially reported to MOHAP for approval.
• Manufacturers are obligated to monitor their products after they enter the market and report any safety incidents to the authority.

Proregulations' UAE MOHAP Registration Services

Our team facilitates a seamless transition into the UAE market by managing the complexities of MOHAP regulations through the following specialized service modules.

• Professional representative and distributor liaison

We assist in establishing the necessary local representation to fulfill the legal requirement for managing your product registrations and communications with MOHAP.

• Regulatory strategy and classification analysis

Our experts conduct a detailed review of your product's intended use and technical features to determine its correct risk class in alignment with UAE guidelines.

• Technical dossier and file compilation

We help prepare the essential technical summaries required by MOHAP including risk management reports and safety performance data.

• MOHAP application and system management

We manage the entire submission process within the MOHAP electronic portal to ensure that all manufacturer information and technical evidence are accurately reported.

• Clinical evidence and technical assessment support

Our team provides guidance on presenting clinical data and verifying your technical documentation to satisfy MOHAP evaluations.

• Compliance maintenance and license renewal

We ensure your market access remains uninterrupted by managing the necessary updates for your registration and coordinating the renewal of certificates.

• Labeling and technical documentation review

We review your product labels and instructions for use to ensure they meet the specific technical requirements mandated by UAE law.

If you are interested in our UAE MOHAP registration services and wish to secure your market position, please feel free to contact us.